The medical course of CLL is quite heterogeneous, starting from a fairly asymptomatic sickness which could even regress spontaneously into a progressive illness that sooner or later leads to the patient’s Dying, so there has normally been exceptional desire in pinpointing the prognosis of personal patients. Although many prognostic markers are ac